The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of “Hold” from Analysts

The Beauty Health Company (NASDAQ:SKIN) has been given an average rating of “Hold” by the eight analysts that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $2.02.

Several research firms recently weighed in on SKIN. Zacks Research cut Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. Weiss Ratings downgraded shares of Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday. Roth Capital reaffirmed a “buy” rating and issued a $2.00 target price (down from $2.50) on shares of Beauty Health in a research report on Wednesday, May 20th. Finally, Canaccord Genuity Group cut their price target on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Friday, May 1st.

Beauty Health Stock Performance

Shares of SKIN stock opened at $0.73 on Monday. The company has a market cap of $94.89 million, a P/E ratio of -4.31 and a beta of 1.08. The firm has a fifty day moving average price of $0.73 and a 200 day moving average price of $0.97. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37. Beauty Health has a 12 month low of $0.55 and a 12 month high of $2.69.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04. The company had revenue of $64.91 million for the quarter, compared to analysts’ expectations of $66.28 million. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%. Sell-side analysts predict that Beauty Health will post -0.16 earnings per share for the current fiscal year.

Institutional Trading of Beauty Health

Large investors have recently made changes to their positions in the company. Capricorn Fund Managers Ltd acquired a new position in Beauty Health in the 1st quarter valued at about $17,270,000. Woodline Partners LP grew its stake in shares of Beauty Health by 255.9% in the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock valued at $11,801,000 after purchasing an additional 4,263,997 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Beauty Health by 127.0% in the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after purchasing an additional 3,225,668 shares during the period. Soleus Capital Management L.P. purchased a new stake in shares of Beauty Health during the second quarter worth approximately $1,910,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Beauty Health by 27.5% during the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after purchasing an additional 496,963 shares during the period. 93.26% of the stock is owned by institutional investors and hedge funds.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.